دورية أكاديمية

Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.

التفاصيل البيبلوغرافية
العنوان: Syntheses and structure-activity relationships of taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III.
المؤلفون: Ojima I; Department of Chemistry, State University of New York at Stony Brook 11794-3400, USA., Slater JC, Kuduk SD, Takeuchi CS, Gimi RH, Sun CM, Park YH, Pera P, Veith JM, Bernacki RJ
المصدر: Journal of medicinal chemistry [J Med Chem] 1997 Jan 31; Vol. 40 (3), pp. 267-78.
نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Print ISSN: 0022-2623 (Print) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
أسماء مطبوعة: Publication: Washington Dc : American Chemical Society
Original Publication: [Easton, Pa.] : American Chemical Society, [c1963-
مواضيع طبية MeSH: Taxoids*, Antineoplastic Agents, Phytogenic/*chemical synthesis , Antineoplastic Agents, Phytogenic/*pharmacology , Paclitaxel/*analogs & derivatives, ATP Binding Cassette Transporter, Subfamily B, Member 1/metabolism ; Antineoplastic Agents, Phytogenic/chemistry ; Antineoplastic Agents, Phytogenic/metabolism ; Docetaxel ; Drug Resistance, Multiple ; Drug Resistance, Neoplasm ; Drug Screening Assays, Antitumor ; Humans ; Magnetic Resonance Spectroscopy ; Molecular Conformation ; Molecular Structure ; Paclitaxel/chemical synthesis ; Paclitaxel/chemistry ; Paclitaxel/metabolism ; Paclitaxel/pharmacology ; Structure-Activity Relationship ; Tumor Cells, Cultured
مستخلص: A series of new taxoids derived from 14 beta-hydroxy-10-deacetylbaccatin III was synthesized by means of the beta-lactam synthon method. Most of the new taxoids thus synthesized possess excellent cytotoxicity against human ovarian (A121), non-small-cell lung (A549), colon (HT-29), and breast (MCF-7) cancer cell lines, and several of these taxoids show subnanomolar IC50 values which are severalfold to 1 order of magnitude better than those of paclitaxel and docetaxel. Modifications at the 3'- and 3'-N-positions exert marked effects on the activity. For the substituents at C-3', the cytotoxicity decreases in the order 2-furyl approximately 2-methyl-1-propenyl > or = 2-methylpropyl > (E)-1-propenyl > or = n-propyl > phenyl > > 2,2-dimethylpropyl. For the 3'-N substituents, the activity decreases in the order t-BuOCO > Ph > n-hexanoyl. A significant increase in the cytotoxicity against the doxorubicin-resistant human breast cancer cell line MCF7-R that expresses the multidrug resistance (MDR) phenotype is observed by the proper modification of the substituent at C-10. The observed remarkable effects of the substituents at C-10 on the activity against MCF7-R can be ascribed to the effective inhibition of the binding of these new taxoids to P-glycoprotein that is responsible for MDR.
معلومات مُعتمدة: GM427980 United States GM NIGMS NIH HHS; NCI 13038 United States CI NCPDCID CDC HHS
المشرفين على المادة: 0 (ATP Binding Cassette Transporter, Subfamily B, Member 1)
0 (Antineoplastic Agents, Phytogenic)
0 (Taxoids)
15H5577CQD (Docetaxel)
P88XT4IS4D (Paclitaxel)
تواريخ الأحداث: Date Created: 19970131 Date Completed: 19970313 Latest Revision: 20181130
رمز التحديث: 20240627
DOI: 10.1021/jm960563e
PMID: 9022793
قاعدة البيانات: MEDLINE
الوصف
تدمد:0022-2623
DOI:10.1021/jm960563e